Miho Iida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Miho Iida has a total of 204 co-authors. Here are the top co-authors by number of shared publications:
- Kouji Banno
Center of Maternal‐Fetal/Neonatal Medicine Hiroshima University Hospital Hiroshima Japan
8 shared publications - Iori Kisu
Department of Obstetrics and Gynecology Keio University School of Medicine Tokyo Japan
4 shared publications - Naoko Miyagawa
Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan
4 shared publications - Sei Harada
Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo 160-8582, Japan (Dr Toki, Dr Harada, Dr Hirata, Dr Iida, Dr Miyagawa, Edagawa, Dr Okamura, and Dr Takebayashi); Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0035, Japan (Dr Harada, Ishikawa, Dr Hirayama, Dr Sugimoto, and Dr Takebayashi)
4 shared publications - Toru Takebayashi
Department of Preventive Medicine and Public Health, Keio University School of Medicine , Tokyo
4 shared publications - Akiko Kubo
Division of Dermatology, Department of Internal Related Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
3 shared publications
Latest Publications
- Open Access
- 27 September 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (10) , e72394
Converting Equol Nonproducers to Producers: A Systematic Review of Randomized Clinical Trials
Soy isoflavones have been associated with benefits for menopausal symptoms, cardiovascular health, and cognitive function, yet randomized clinical trials (RCTs) in Western countries have produced inconsistent results. A key factor may be equol, a metabolite of daidzein with stronger estrogenic and antioxidant effects, produced at lower rates in Western than in East Asian populations. This systematic review evaluates RCTs aimed at converting equol nonproducers to producers (CRD420251038428). We searched PubMed, Embase, and Web of Science for RCTs published between 1991 and 2025. Twelve RCTs ( n = 730, 85.5% female) met inclusion criteria. Interventions included soy isoflavones alone, soy with probiotics, fermented soy products, seaweed, and wheat bran. Studies were conducted in Japan ( n = 1), Brazil ( n = 1), and Western countries ( n = 10), with durations ranging from a single dose to 2.5 years. Study quality was assessed using the National Heart, Lung, and Blood Institute evaluation tool. None of the interventions significantly converted equol nonproducers into producers, with methodological limitations including small sample sizes, inconsistent equol measurement, and heterogeneous populations compromising reliability. Achieving equol producer status could unlock the full nutritional potential of soy isoflavones for menopausal, cardiovascular, and cognitive health. Future studies should prioritize standardized equol measurement, microbiome‐targeted interventions, and well‐powered, diverse populations to develop effective dietary strategies for Western populations where soy intake and equol production remain low.
- 27 September 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (10) , e72394
Open AccessConverting Equol Nonproducers to Producers: A Systematic Review of Randomized Clinical Trials
Soy isoflavones have been associated with benefits for menopausal symptoms, cardiovascular health, and cognitive function, yet randomized clinical trials (RCTs) in Western countries have produced inconsistent results. A key factor may be equol, a metabolite of daidzein with stronger estrogenic and antioxidant effects, produced at lower rates in Western than in East Asian populations. This systematic review evaluates RCTs aimed at converting equol nonproducers to producers (CRD420251038428). We searched PubMed, Embase, and Web of Science for RCTs published between 1991 and 2025. Twelve RCTs ( n = 730, 85.5% female) met inclusion criteria. Interventions included soy isoflavones alone, soy with probiotics, fermented soy products, seaweed, and wheat bran. Studies were conducted in Japan ( n = 1), Brazil ( n = 1), and Western countries ( n = 10), with durations ranging from a single dose to 2.5 years. Study quality was assessed using the National Heart, Lung, and Blood Institute evaluation tool. None of the interventions significantly converted equol nonproducers into producers, with methodological limitations including small sample sizes, inconsistent equol measurement, and heterogeneous populations compromising reliability. Achieving equol producer status could unlock the full nutritional potential of soy isoflavones for menopausal, cardiovascular, and cognitive health. Future studies should prioritize standardized equol measurement, microbiome‐targeted interventions, and well‐powered, diverse populations to develop effective dietary strategies for Western populations where soy intake and equol production remain low.
- Open Access
- 17 August 2026
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 83 (6) , 318-324
Associations of employment characteristics and psychosocial work factors with severe menopausal symptoms among working women: a longitudinal study
To investigate whether employment characteristics and psychosocial work factors are associated with the development of severe menopausal symptoms among working women. We longitudinally analysed 648 working women aged 35-55 years without menopausal symptoms interfering with daily life at baseline (2012-2014). Employment characteristics included employment status, managerial position, shift work and working hours. Psychosocial work factors included workload, job control, job strain and effort-reward imbalance. At follow-up (2018-2020), women in the menopausal transition or postmenopause who reported menopausal symptoms that interfered with daily life during follow-up were classified as having developed severe menopausal symptoms. Associations between baseline work factors and the development of severe menopausal symptoms were examined using modified Poisson regression adjusted for age, follow-up duration, body mass index, smoking, drinking and educational attainment. Symptom domains (vasomotor, psychological and physical) were also evaluated. During 5.3±0.5 years of follow-up, 68 women (10.5%) developed severe menopausal symptoms. Per 1-SD increase, higher workload (risk ratio (RR) 1.34, 95% CI 1.04 to 1.73), job strain ratio (RR 1.30, 95% CI 1.10 to 1.54) and effort-reward ratio (RR 1.23, 95% CI 0.99 to 1.51) were associated with a higher risk, whereas higher job control was protective (RR 0.78, 95% CI 0.63 to 0.97). Results were similar after additional adjustment for menopausal, marital and parental status. Domain-specific analyses showed similar associations across symptoms, strongest for physical symptom severity. Psychosocial work factors, particularly high workload, low job control and high job strain, were associated with the development of severe menopausal symptoms. These findings highlight the importance of psychosocial work environments in supporting women during the menopausal transition.
- 17 August 2026
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 83 (6) , 318-324
Open AccessAssociations of employment characteristics and psychosocial work factors with severe menopausal symptoms among working women: a longitudinal study
To investigate whether employment characteristics and psychosocial work factors are associated with the development of severe menopausal symptoms among working women. We longitudinally analysed 648 working women aged 35-55 years without menopausal symptoms interfering with daily life at baseline (2012-2014). Employment characteristics included employment status, managerial position, shift work and working hours. Psychosocial work factors included workload, job control, job strain and effort-reward imbalance. At follow-up (2018-2020), women in the menopausal transition or postmenopause who reported menopausal symptoms that interfered with daily life during follow-up were classified as having developed severe menopausal symptoms. Associations between baseline work factors and the development of severe menopausal symptoms were examined using modified Poisson regression adjusted for age, follow-up duration, body mass index, smoking, drinking and educational attainment. Symptom domains (vasomotor, psychological and physical) were also evaluated. During 5.3±0.5 years of follow-up, 68 women (10.5%) developed severe menopausal symptoms. Per 1-SD increase, higher workload (risk ratio (RR) 1.34, 95% CI 1.04 to 1.73), job strain ratio (RR 1.30, 95% CI 1.10 to 1.54) and effort-reward ratio (RR 1.23, 95% CI 0.99 to 1.51) were associated with a higher risk, whereas higher job control was protective (RR 0.78, 95% CI 0.63 to 0.97). Results were similar after additional adjustment for menopausal, marital and parental status. Domain-specific analyses showed similar associations across symptoms, strongest for physical symptom severity. Psychosocial work factors, particularly high workload, low job control and high job strain, were associated with the development of severe menopausal symptoms. These findings highlight the importance of psychosocial work environments in supporting women during the menopausal transition.
- Open Access
- 5 February 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (4) , 806-816
Serum total apoptosis inhibitor of macrophage, metabolomic signatures, and incident dyslipidemia: A population-based prospective study
- 5 February 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (4) , 806-816
Open AccessSerum total apoptosis inhibitor of macrophage, metabolomic signatures, and incident dyslipidemia: A population-based prospective study
- Open Access
- 6 January 2026
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 68 (1)
Development of a Workplace Health Initiatives Checklist for Women and its cross-sectional associations with burnout, productivity, and satisfaction
Objectives: To develop a Workplace Health Initiatives Checklist for Women (WHIC‑W), we assessed content validity (expert) and provided initial evidence for construct validity by examining hypothesized cross-sectional associations with burnout, productivity, and job satisfaction. Methods: A multidisciplinary expert panel comprising gynecologists, occupational physicians, nurses, industrial hygienists, and psychosomatic specialists created 26 items for the WHIC‑W. A survey was conducted in October 2023 with 3343 working women aged 20-69 years. The checklist includes 2 domains: Domain 1 (15 items on work environment) and Domain 2 (11 items on pregnancy, child/elderly care, and support for balancing illness and work). The outcome included the Copenhagen Burnout Inventory, work productivity using presenteeism (WHO Health and Work Performance Questionnaire) and absenteeism (health-related days off in the past 28 days), satisfaction rated on a visual analog scale (0-10), and intention to resign over the past year. Results: The checklist was scored on a 26-point scale, with a median score of 3 (interquartile range: 1-9), indicating limited workplace support for women. Higher checklist total scores were associated with lower personal burnout (β = −0.32, 95% CI: −0.435 to −0.196), work-related burnout (β = −0.30, 95% CI: −0.395 to −0.207), and client-related burnout (β = −0.17, 95% CI: −0.276 to −0.065), and higher absolute presenteeism (β = 0.43, 95% CI: 0.336-0.516; higher score = less performance loss), absenteeism (OR = 1.01, 95% CI: 1.001-1.021), and satisfaction (OR = 1.07, 95% CI: 1.055-1.079). Conclusions: This study provides preliminary construct validity evidence supporting WHIC-W as a formative checklist, with higher scores showing hypothesized cross-sectional associations with lower burnout, better productivity, and job satisfaction.
- 6 January 2026
- Published by Oxford University Press (OUP) in Journal of Occupational Health
- Vol. 68 (1)
Open AccessDevelopment of a Workplace Health Initiatives Checklist for Women and its cross-sectional associations with burnout, productivity, and satisfaction
Objectives: To develop a Workplace Health Initiatives Checklist for Women (WHIC‑W), we assessed content validity (expert) and provided initial evidence for construct validity by examining hypothesized cross-sectional associations with burnout, productivity, and job satisfaction. Methods: A multidisciplinary expert panel comprising gynecologists, occupational physicians, nurses, industrial hygienists, and psychosomatic specialists created 26 items for the WHIC‑W. A survey was conducted in October 2023 with 3343 working women aged 20-69 years. The checklist includes 2 domains: Domain 1 (15 items on work environment) and Domain 2 (11 items on pregnancy, child/elderly care, and support for balancing illness and work). The outcome included the Copenhagen Burnout Inventory, work productivity using presenteeism (WHO Health and Work Performance Questionnaire) and absenteeism (health-related days off in the past 28 days), satisfaction rated on a visual analog scale (0-10), and intention to resign over the past year. Results: The checklist was scored on a 26-point scale, with a median score of 3 (interquartile range: 1-9), indicating limited workplace support for women. Higher checklist total scores were associated with lower personal burnout (β = −0.32, 95% CI: −0.435 to −0.196), work-related burnout (β = −0.30, 95% CI: −0.395 to −0.207), and client-related burnout (β = −0.17, 95% CI: −0.276 to −0.065), and higher absolute presenteeism (β = 0.43, 95% CI: 0.336-0.516; higher score = less performance loss), absenteeism (OR = 1.01, 95% CI: 1.001-1.021), and satisfaction (OR = 1.07, 95% CI: 1.055-1.079). Conclusions: This study provides preliminary construct validity evidence supporting WHIC-W as a formative checklist, with higher scores showing hypothesized cross-sectional associations with lower burnout, better productivity, and job satisfaction.
- Open Access
- 13 December 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (6) , e1672-e1680
Longitudinal Study of Plasma Metabolites During Menopause and Their Associations With Later Onset of Metabolic Syndrome
Context: Previous metabolomics studies suggest potential associations between menopausal changes in lipids and an increased risk of metabolic syndrome (MetS). However, longitudinal data on other key metabolites, such as branched-chain amino acids (BCAAs) and homocysteine, remain limited, and most studies lack long-term follow-up across the menopause transition. Objective: This study aimed to investigate longitudinal changes in circulating metabolites during menopause over a mean follow-up of 5 years and assess their associations with subsequent MetS development. Methods: Premenopausal women from the Tsuruoka Metabolomics Cohort Study who participated in at least one follow-up survey were included. Menopausal status, data on MetS, and plasma metabolites profiled using capillary electrophoresis mass spectrometry were assessed at each visit. Thirty-one metabolites were examined for associations with menopausal status using mixed-effects models. The association of these menopause-related metabolites with MetS development was examined via logistic regression analysis adjusted for follow-up duration. Results: Among 953 women (aged 43.8 ± 5.4 years), 316 (33.2%) reached menopause during follow-up (5.0 ± 1.1 years). Eighteen metabolites changed significantly with menopause, particularly those related to BCAA metabolism, urea cycle, and homocysteine metabolism. Of 695 women without MetS at baseline, 65 (9.4%) developed MetS. Glutamate (odds ratio [95% CI]: 1.95 [1.49-2.57]) was associated with higher MetS risk. Higher levels of glutamate, valine, leucine, and cystine were significantly associated with the development of hyperglycemia. Conclusion: Longitudinal changes in charged metabolites occur across the menopausal transition, with specific metabolites such as glutamate possibly contributing to the metabolic alterations underlying increased MetS risk.
- 13 December 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (6) , e1672-e1680
Open AccessLongitudinal Study of Plasma Metabolites During Menopause and Their Associations With Later Onset of Metabolic Syndrome
Context: Previous metabolomics studies suggest potential associations between menopausal changes in lipids and an increased risk of metabolic syndrome (MetS). However, longitudinal data on other key metabolites, such as branched-chain amino acids (BCAAs) and homocysteine, remain limited, and most studies lack long-term follow-up across the menopause transition. Objective: This study aimed to investigate longitudinal changes in circulating metabolites during menopause over a mean follow-up of 5 years and assess their associations with subsequent MetS development. Methods: Premenopausal women from the Tsuruoka Metabolomics Cohort Study who participated in at least one follow-up survey were included. Menopausal status, data on MetS, and plasma metabolites profiled using capillary electrophoresis mass spectrometry were assessed at each visit. Thirty-one metabolites were examined for associations with menopausal status using mixed-effects models. The association of these menopause-related metabolites with MetS development was examined via logistic regression analysis adjusted for follow-up duration. Results: Among 953 women (aged 43.8 ± 5.4 years), 316 (33.2%) reached menopause during follow-up (5.0 ± 1.1 years). Eighteen metabolites changed significantly with menopause, particularly those related to BCAA metabolism, urea cycle, and homocysteine metabolism. Of 695 women without MetS at baseline, 65 (9.4%) developed MetS. Glutamate (odds ratio [95% CI]: 1.95 [1.49-2.57]) was associated with higher MetS risk. Higher levels of glutamate, valine, leucine, and cystine were significantly associated with the development of hyperglycemia. Conclusion: Longitudinal changes in charged metabolites occur across the menopausal transition, with specific metabolites such as glutamate possibly contributing to the metabolic alterations underlying increased MetS risk.
- 7 November 2025
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 36 (3) , 345-352
Changes in rheumatoid arthritis medication in pregnancy: a retrospective observational study using a Japanese claims database
Objectives: To examine changes in rheumatoid arthritis (RA) medication prescriptions during the peri-delivery period, and to explore recent RA prescription trends using a Japanese claims database. Methods: This retrospective observational cohort study used an insurance claims database provided by JMDC Inc. We identified pregnant women with RA who delivered between April 2018 and October 2023. The outcome was the initiation or resumption of intensive treatment after delivery, defined as new or restarting of biologic disease modifying anti-rheumatic drugs (DMARDs), targeted synthetic DMARDs, oral corticosteroids (OCS), or methotrexate. Results: We identified 229 mothers with RA and 246 deliveries. Intensive treatment was initiated in 55 (22.4%) deliveries. Continuation of the same prescription from before delivery was observed in 106 (43.1%) deliveries. The most frequent new prescription postpartum was methotrexate in 18 (7.3%) deliveries. OCS were the most commonly prescribed medications throughout the observation period. Tumour necrosis factor alpha inhibitors were prescribed at similar rates as OCS before pregnancy and in the first trimester, but declined during the second and third trimesters, and returned postpartum. Conclusions: The number of deliveries that required intensive treatment postpartum was lower than in previous studies. Our results suggest that the latest guidelines for pregnant women with RA help control disease activity.
- 7 November 2025
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 36 (3) , 345-352
Changes in rheumatoid arthritis medication in pregnancy: a retrospective observational study using a Japanese claims database
Objectives: To examine changes in rheumatoid arthritis (RA) medication prescriptions during the peri-delivery period, and to explore recent RA prescription trends using a Japanese claims database. Methods: This retrospective observational cohort study used an insurance claims database provided by JMDC Inc. We identified pregnant women with RA who delivered between April 2018 and October 2023. The outcome was the initiation or resumption of intensive treatment after delivery, defined as new or restarting of biologic disease modifying anti-rheumatic drugs (DMARDs), targeted synthetic DMARDs, oral corticosteroids (OCS), or methotrexate. Results: We identified 229 mothers with RA and 246 deliveries. Intensive treatment was initiated in 55 (22.4%) deliveries. Continuation of the same prescription from before delivery was observed in 106 (43.1%) deliveries. The most frequent new prescription postpartum was methotrexate in 18 (7.3%) deliveries. OCS were the most commonly prescribed medications throughout the observation period. Tumour necrosis factor alpha inhibitors were prescribed at similar rates as OCS before pregnancy and in the first trimester, but declined during the second and third trimesters, and returned postpartum. Conclusions: The number of deliveries that required intensive treatment postpartum was lower than in previous studies. Our results suggest that the latest guidelines for pregnant women with RA help control disease activity.
- Open Access
- 7 November 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-12
Development and validation of a premenstrual symptom screening tool for working women in relation to absenteeism
This study aimed to develop and validate a screening tool tailored for working women to comprehensively assess premenstrual symptoms—including physical, psychological, and work-related domains—and to examine its reliability, validity, and association with absenteeism. In October 2021, a multidisciplinary expert panel comprising a gynecologist, a psychosomatic physician, a psychologist, occupational health specialists, and data scientists developed a set of 47 original items. We then recruited 3,239 working women with menstruation via an internet research company and administered these items to assess PMS-related symptoms. For scale development, we conducted exploratory and confirmatory factor analyses, along with evaluations using Cronbach’s alpha, receiver operating characteristic analysis, and logistic regression analysis. Of the participants, 331 women had experienced PMS (10%), and 393 women had taken sick leave because of PMS-associated symptoms (12%). Exploratory factor analyses with maximum likelihood and Promax rotation identified four domains with 27 items, including “Somatic symptoms’’ (Cronbach’s α = 0.93), “Psychological symptoms” (Cronbach’s α = 0.94), “Lack of work efficiency” (Cronbach’s α = 0.93), and “Abdominal symptoms” (Cronbach’s α = 0.95). Using a split-half sample for the confirmatory factor analysis, the four-factor solution demonstrated acceptable model fit (RMSEA = 0.077, CFI = 0.928). The Average Variance Extracted values ranged from 0.54 to 0.68 across the four domains, and in all cases, the square root of AVE exceeded the corresponding inter-factor correlations, supporting the discriminant validity using the Fornell–Larcker criterion. We also confirmed the developed scale’s criterion validity using existing PMS screening criteria and its concurrent validity through moderate correlation coefficients with Copenhagen Burnout Inventory scores. The receiver operating characteristic curve yielded a moderate construct ability for work absenteeism, including a sensitivity of 78%, a specificity of 57%, and an area under the curve of 0.735. A moderately reliable and valid new scale for PMS for working women was developed with efficacy for screening for work absenteeism.
- 7 November 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-12
Open AccessDevelopment and validation of a premenstrual symptom screening tool for working women in relation to absenteeism
This study aimed to develop and validate a screening tool tailored for working women to comprehensively assess premenstrual symptoms—including physical, psychological, and work-related domains—and to examine its reliability, validity, and association with absenteeism. In October 2021, a multidisciplinary expert panel comprising a gynecologist, a psychosomatic physician, a psychologist, occupational health specialists, and data scientists developed a set of 47 original items. We then recruited 3,239 working women with menstruation via an internet research company and administered these items to assess PMS-related symptoms. For scale development, we conducted exploratory and confirmatory factor analyses, along with evaluations using Cronbach’s alpha, receiver operating characteristic analysis, and logistic regression analysis. Of the participants, 331 women had experienced PMS (10%), and 393 women had taken sick leave because of PMS-associated symptoms (12%). Exploratory factor analyses with maximum likelihood and Promax rotation identified four domains with 27 items, including “Somatic symptoms’’ (Cronbach’s α = 0.93), “Psychological symptoms” (Cronbach’s α = 0.94), “Lack of work efficiency” (Cronbach’s α = 0.93), and “Abdominal symptoms” (Cronbach’s α = 0.95). Using a split-half sample for the confirmatory factor analysis, the four-factor solution demonstrated acceptable model fit (RMSEA = 0.077, CFI = 0.928). The Average Variance Extracted values ranged from 0.54 to 0.68 across the four domains, and in all cases, the square root of AVE exceeded the corresponding inter-factor correlations, supporting the discriminant validity using the Fornell–Larcker criterion. We also confirmed the developed scale’s criterion validity using existing PMS screening criteria and its concurrent validity through moderate correlation coefficients with Copenhagen Burnout Inventory scores. The receiver operating characteristic curve yielded a moderate construct ability for work absenteeism, including a sensitivity of 78%, a specificity of 57%, and an area under the curve of 0.735. A moderately reliable and valid new scale for PMS for working women was developed with efficacy for screening for work absenteeism.
- Open Access
- 5 August 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (8) , 363-364
Recognizing Female Reproductive Factors in Interpreting Changes in Disease Burden Among Populations
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 5 August 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (8) , 363-364
Open AccessRecognizing Female Reproductive Factors in Interpreting Changes in Disease Burden Among Populations
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- Open Access
- 5 August 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (8) , 393-401
Study Profile of the Tsuruoka Metabolomics Cohort Study (TMCS)
The Tsuruoka Metabolomics Cohort Study (TMCS) is an ongoing population-based cohort study being conducted in the rural area of Yamagata Prefecture, Japan. This study aimed to enhance the precision prevention of multi-factorial, complex diseases, including non-communicable and aging-associated diseases, by improving risk stratification and prediction measures. At baseline, 11,002 participants aged 35–74 years were recruited in Tsuruoka City, Yamagata Prefecture, Japan, between 2012 and 2015, with an ongoing follow-up survey. Participants underwent various measurements, examinations, tests, and questionnaires on their health, lifestyle, and social factors. This study used an integrative approach with deep molecular profiling to identify potential biomarkers linked to phenotypes that underpin disease pathophysiology and provide better mechanistic insights into social health determinants. The TMCS incorporates multi-omics data, including genetic and metabolomic analyses of 10,933 participants and comprehensive data collection ranging from physical, psychological, behavioral, and social to biological data. The metabolome is used as a phenotypic probe because it is sensitive to changes in physiological and external conditions. The TMCS focuses on collecting outcomes for cardiovascular disease, cancer incidence and mortality, disability, functional decline due to aging and disease sequelae, and the variation in health status within the body represented by omics analysis that lies between exposure and disease. It contains several sub-studies on aging, heated tobacco products, and women's health. This study is notable for its robust design, high participation rate (89%), and long-term repeated surveys. Moreover, it contributes to precision prevention in Japan and East Asia as a well-established multi-omics platform.
- 5 August 2024
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 34 (8) , 393-401
Open AccessStudy Profile of the Tsuruoka Metabolomics Cohort Study (TMCS)
The Tsuruoka Metabolomics Cohort Study (TMCS) is an ongoing population-based cohort study being conducted in the rural area of Yamagata Prefecture, Japan. This study aimed to enhance the precision prevention of multi-factorial, complex diseases, including non-communicable and aging-associated diseases, by improving risk stratification and prediction measures. At baseline, 11,002 participants aged 35–74 years were recruited in Tsuruoka City, Yamagata Prefecture, Japan, between 2012 and 2015, with an ongoing follow-up survey. Participants underwent various measurements, examinations, tests, and questionnaires on their health, lifestyle, and social factors. This study used an integrative approach with deep molecular profiling to identify potential biomarkers linked to phenotypes that underpin disease pathophysiology and provide better mechanistic insights into social health determinants. The TMCS incorporates multi-omics data, including genetic and metabolomic analyses of 10,933 participants and comprehensive data collection ranging from physical, psychological, behavioral, and social to biological data. The metabolome is used as a phenotypic probe because it is sensitive to changes in physiological and external conditions. The TMCS focuses on collecting outcomes for cardiovascular disease, cancer incidence and mortality, disability, functional decline due to aging and disease sequelae, and the variation in health status within the body represented by omics analysis that lies between exposure and disease. It contains several sub-studies on aging, heated tobacco products, and women's health. This study is notable for its robust design, high participation rate (89%), and long-term repeated surveys. Moreover, it contributes to precision prevention in Japan and East Asia as a well-established multi-omics platform.
- Open Access
- 22 January 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (1) , 77
Reliability of Time-Series Plasma Metabolome Data over 6 Years in a Large-Scale Cohort Study
Studies examining long-term longitudinal metabolomic data and their reliability in large-scale populations are limited. Therefore, we aimed to evaluate the reliability of repeated measurements of plasma metabolites in a prospective cohort setting and to explore intra-individual concentration changes at three time points over a 6-year period. The study participants included 2999 individuals (1317 men and 1682 women) from the Tsuruoka Metabolomics Cohort Study, who participated in all three surveys—at baseline, 3 years, and 6 years. In each survey, 94 plasma metabolites were quantified for each individual and quality control (QC) sample. The coefficients of variation of QC, intraclass correlation coefficients, and change rates of QC were calculated for each metabolite, and their reliability was classified into three categories: excellent, fair to good, and poor. Seventy-six percent (71/94) of metabolites were classified as fair to good or better. Of the 39 metabolites grouped as excellent, 29 (74%) in men and 26 (67%) in women showed significant intra-individual changes over 6 years. Overall, our study demonstrated a high degree of reliability for repeated metabolome measurements. Many highly reliable metabolites showed significant changes over the 6-year period, suggesting that repeated longitudinal metabolome measurements are useful for epidemiological studies.
- 22 January 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (1) , 77
Open AccessReliability of Time-Series Plasma Metabolome Data over 6 Years in a Large-Scale Cohort Study
Studies examining long-term longitudinal metabolomic data and their reliability in large-scale populations are limited. Therefore, we aimed to evaluate the reliability of repeated measurements of plasma metabolites in a prospective cohort setting and to explore intra-individual concentration changes at three time points over a 6-year period. The study participants included 2999 individuals (1317 men and 1682 women) from the Tsuruoka Metabolomics Cohort Study, who participated in all three surveys—at baseline, 3 years, and 6 years. In each survey, 94 plasma metabolites were quantified for each individual and quality control (QC) sample. The coefficients of variation of QC, intraclass correlation coefficients, and change rates of QC were calculated for each metabolite, and their reliability was classified into three categories: excellent, fair to good, and poor. Seventy-six percent (71/94) of metabolites were classified as fair to good or better. Of the 39 metabolites grouped as excellent, 29 (74%) in men and 26 (67%) in women showed significant intra-individual changes over 6 years. Overall, our study demonstrated a high degree of reliability for repeated metabolome measurements. Many highly reliable metabolites showed significant changes over the 6-year period, suggesting that repeated longitudinal metabolome measurements are useful for epidemiological studies.